Literature DB >> 427726

Diagnosis of minimal breast cancers in the BCDDP: the 66 questionable cases.

O H Beahrs, C R Smart.   

Abstract

Of 1,810 breast cancers detected in the NCI/ACS Breast Cancer Detection Demonstration Projects, 592 were less than 1 cm in diameter and considered minimal; and tissue slides from 506 of them were available for retrospective review by a panel of pathologists. The initial report of this review indicated that in 66 cases the pathologic features of the presented slides were not sufficient for diagnosis of cancer. Subsequent investigation revealed that, through computer error, the slides submitted in 2 of these 66 cases were not from the lesions in question but from blind biopsy of the contralateral breast. Further review by the pathology panel of tissue from 38 of the 64 remaining cases determined that 16 of the remaining lesions were indeed cancers or borderline malignant lesions. This then left 48 cases in doubt. Only biopsy had been performed in 11 of them, and some form of mastectomy in the other 37. The original pathologic opinion had been divided in 30 of these, and the mastectomy had been delayed for 1 day to 7 months after the biopsy. In only 7 of the 48 questionable cases was definitive treatment carried out at the time of biopsy. All in all, these findings reflect sound, responsible surgical judgment.

Entities:  

Mesh:

Year:  1979        PMID: 427726     DOI: 10.1002/1097-0142(197903)43:3<848::aid-cncr2820430310>3.0.co;2-1

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Treatment and survival of female patients with nonpalpable breast carcinoma.

Authors:  J G Tinnemans; T Wobbes; R Holland; J H Hendriks; R F Van der Sluis; H H De Boer
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

2.  The Stockholm breast cancer screening trial--5-year results and stage at discovery.

Authors:  J Frisell; G Eklund; L Hellström; U Glas; A Somell
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

3.  Randomized mammographic screening for breast cancer in Stockholm. Design, first round results and comparisons.

Authors:  J Frisell; U Glas; L Hellström; A Somell
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 4.  Screening for breast cancer.

Authors:  A B Miller
Journal:  Breast Cancer Res Treat       Date:  1983       Impact factor: 4.872

5.  A proposal for short-term quality control in breast cancer screening.

Authors:  A L Verbeek; M C Van den Ban; J H Hendriks
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.